Albany, New York, September 14, 2017: MRRSE (Market Research Report Search Engine) has included a comprehensive insightful research on this topic and the report is titled “Peptide Therapeutics Market - Global Industry Analysis, Growth, Size, Trends, Share and Forecast 2016 - 2024”.
This research gives a broad overview of the market considering all major aspects sufficient enough to assist the reader decide on goals and set up benchmarks. All latest trends, developments and opportunities are covered in this research. Moreover, the growth of the entire market is impacted by several factors. All these are analyzed in detail and the impact level of these factors is slated. A detailed market segmentation is carried out which gives justice to the credibility of the research report. Future projections have been carried out for a duration of eight years. All data and statistical analyses have been carried out considering all major regions of North America, Asia Pacific (APAC), Europe, Latin America and Middle East and Africa (MEA).
Global Peptide Therapeutics Market: Forecast
The global peptide therapeutics market is projected to grow at a CAGR of 9.10% throughout the assessment period, 2016-2024. The market, in 2015, was valued at US$ 21.3 Bn and is projected to reflect a value of about US$ 46 Bn by the end of 2024.
Global Peptide Therapeutics Market: Segmental Analysis
The global market for peptide therapeutics has been segmented by application (cancer, CVD, metabolic, GIT, respiratory, dermatology, anti-infective, renal, CNS, others), by route of administration (oral, parental, others), by type (generic and innovative), by technology (solid phase, liquid phase and hybrid phase), by type of molecule (vasopressin, calcitonin, somatostatin, natriuretic, immunopeptide, others), by API peptide type (CMO and In-house) and by geography.
Global Peptide Therapeutics Market: Dynamics
The global market for peptide therapeutics is poised to witness significant growth. Increasing prevalence of cancer and metabolic disorders are the main factors fuelling the development of the entire market. There have been increased developments in medical science giving rise to different technological advancements in the medical and biopharmaceutical field. The development of peptide drugs at comparatively lower costs of production is spurring the evolution of the global market for peptide therapeutics.
The development of new drugs to treat cancer, owing to rise in the number of patients affected with cancer has a major role in driving the expansion of the peptide therapeutic market on a worldwide basis. However, a main limitation associated with peptide with respect to its complexity can hinder the growth process of the global market for peptide therapeutics.
Global Peptide Therapeutics Market: Competition Scenario
The research report on global peptide therapeutics market has profiled tier companies involved in the market. Key tier companies such as Amgen Inc., Bachem Holding AG, Eli Lilly and Co., F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Novartis AG, Pfizer Inc., Sanofi, Takeda Pharmaceutical Co. Ltd., and Teva Pharmaceutical Industries Ltd. are covered in this research report.
Browse Full Global Peptide Therapeutics Market Report with TOC : http://www.mrrse.com/peptide-therapeutics-market
Market Research Reports Search Engine (MRRSE) is an industry-leading database of market intelligence reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords.
MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.
90, State Street
Albany, NY - 12207